The estimated Net Worth of Investment Fund Ltd Bristol... is at least $6.63 Million dollars as of 18 September 2023. Investment Bristol owns over 1,150,000 units of Research Solutions stock worth over $3,809,407 and over the last few years Investment sold RSSS stock worth over $2,817,500.
Sign up
Investment Bristol RSSS stock SEC Form 4 insiders trading
Investment has made over 1 trades of the Research Solutions stock since 2023, according to the Form 4 filled with the SEC. Most recently Investment sold 1,150,000 units of RSSS stock worth $2,817,500 on 18 September 2023.
The largest trade Investment's ever made was selling 1,150,000 units of Research Solutions stock on 18 September 2023 worth over $2,817,500. On average, Investment trades about 1,150,000 units every 0 days since 2023. As of 18 September 2023 Investment still owns at least 1,432,108 units of Research Solutions stock.
You can see the complete history of Investment Bristol stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at Research Solutions
Over the last 6 years, insiders at Research Solutions have traded over $23,496,493 worth of Research Solutions stock and bought 5,075 units worth $10,503 . The most active insiders traders include West Capital Management Lp 12, Investment Fund Ltd Bristol, and Investment Fund Ltd Bristol.... On average, Research Solutions executives and independent directors trade stock every 21 days with the average trade being worth of $314,566. The most recent stock trade was executed by Peter Derycz on 20 March 2024, trading 69,495 units of RSSS stock currently worth $199,451.
What does Research Solutions do?
Research Solutions, Inc., through its subsidiaries, provides cloud-based software-as-a-service research platform. The company is also involved in the transactional sale of published scientific, technical, and medical (STM) content managed, sourced, and delivered through the Transactions platform. Its solutions enable life science and other research intensive organizations to accelerate their research and development activities with access and management STM articles used throughout the intellectual property development lifecycle. The company was formerly known as Derycz Scientific, Inc. and changed its name to Research Solutions, Inc. in March 2013. Research Solutions, Inc. was founded in 2006 and is based in Henderson, Nevada.
What does Research Solutions's logo look like?
Complete history of Investment Bristol stock trades at Research Solutions
Research Solutions executives and stock owners
Research Solutions executives and other stock owners filed with the SEC include:
-
Roy W. Olivier,
CEO, Pres & Director -
Peter Derycz,
President, Chief Executive Officer, Director -
Peter Victor Derycz,
Founder & Exec. Chairman -
Alan Urban,
Chief Financial Officer, Secretary -
Alan Louis Urban CPA,
Exec. Officer -
Scott Ahlberg,
Chief Operating Officer -
Alan Louis Urban,
CFO & Sec. -
Scott Ahlberg,
Chief Operating Officer -
Roy Olivier,
Independent Director -
Merrill McPeak,
Independent Director -
Chad Cooper,
Independent Director -
Rogier Van Erkel,
Chief Sales Officer -
Michiel van der Heijden,
Chief Product Officer -
Yohann Georgel,
Chief Marketing Officer -
Marc Nissan,
Chief Technology Officer -
John Regazzi,
Independent Chairman of the Board -
Shane Alan Hunt,
Chief Customer Success Officer -
Tedd Adams,
Director of Sales -
Marc Nissan,
Chief Technology Officer -
Frank Buckley,
Account Mang. -
William A. Nurthen,
Chief Financial Officer -
Michiel van der Heijden,
Chief Product Officer -
Shane Hunt,
Chief Customer Success Officer -
Rogier van Erkel,
Chief Revenue Officer -
Mitja-Alexander Linss,
Director of Marketing -
Barbara J. Cooperman,
Director -
Investment Fund Ltd Bristol...,
-
Eugene Vlad Robin,
Director -
West Capital Management Lp 12,
-
Investment Fund Ltd Bristol,
10% owner -
William Nurthen,
CFO & Secretary -
Shane Alan Hunt,
Chief Revenue Officer -
Jeremy Murphy,
Director -
Kenneth L Gayron,
Director